# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-13-314875
Filing Date
2013-08-01
Accepted
2013-08-01 15:00:38
Documents
3
Effectiveness Date
2013-08-01

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | d574956ddefa14a.htm | DEFA14A | 23011
2 | GRAPHIC | g574956g37m51.jpg | GRAPHIC | 317903
3 | GRAPHIC | g574956g82x74.jpg | GRAPHIC | 348671
| Complete submission text file | 0001193125-13-314875.txt |  | 942902

Mailing Address 8001 ARISTA PLACE SUITE 430 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 430 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-22873 | Film No.: 131002380
SIC: 2835 In Vitro & In Vivo Diagnostic Substances